Danielle Aymar, a 31-year-old doctor from Recife, prescribes cannabis. Since 2022, his interest in the science of endocannabinoids became evident after his sister was diagnosed with autism. After several medications, cannabis proved to be the solution. From this experience, Danielle took specialized courses and followed therapeutic treatments.
While treating her sister, Danielle noticed a significant improvement in the patient’s independence, as she became more aware and active. “Nowadays, she has a conscience, she works, and she is much calmer,” he says. This motivated her to treat other people in the family, gradually expanding her scope of care.
After specializing, Danielle began seeing an increasing number of patients. However, she notes that many have concerns about how to proceed with treatment. For her, the starting point is faith. “The only thing the patient needs to do is agree to the treatment and adhere to it. Because it is very therapeutic.”
Due to the diversity of patients, each clinical case should be treated in a personalized manner, with responsibility and professional monitoring. But in the end, what should a patient know when interested in treatment or when starting treatment? This skepticism prompted Danielle to highlight points that could facilitate understanding of cannabis and bring people from outside this medical context together.
“The first step is to monitor the patient with each dose, because even though you have an expectation of the dose, each organism works differently. So, the same dose for two patients of the same weight and condition could work differently in each of them. We need to” Monitoring when improvement or decline begins, encourages the patient to continue,” explains Danielle, reinforcing the importance of monitoring treatment.
According to her, it is necessary for the patient to learn about the treatment. “With a scientific basis, it is proven to be a safe and effective treatment. The patient needs to feel comfortable and confident to start the treatment. After that, the doctor is responsible for guiding and providing the necessary information to obtain and import the medicine and if there is a mild side effect, the doctor can easily correct it.”
The patient must follow the instructions specified by the doctor. “It is a treatment that requires monitoring until we reach the optimal therapeutic dose. In some cases, multidisciplinary treatment is important. We may need to be monitored by a psychiatrist, neurologist, cardiologist, physiotherapist and psychiatrist. Therefore, this multidisciplinary monitoring is necessary “Daniel says.
Brazilian Medical Cannabis Congress
On the 23rd, 24th and 25th of this month, the Third Brazilian Medical Cannabis Congress will be held at the Expo Norte Center, with the participation of more than 100 speakers. Danielle Aymar will be present for the first time at this event on the 24th and 25th and for the professionals it is an opportunity to improve her knowledge.
“I look forward to gaining new science-based knowledge, learning about endocannabinoid medicine through the eyes and experiences of other professionals and sharing my experiences at this event,” she commented.
It is the main scientific and professional conference in Latin America, seeking innovations and advances in the medical field within Brazil. It is aimed at health professionals, researchers, business people and others interested in the topic.
More information can be accessed on social media or on the website: congresscannabis.com.br.
“Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast.”
